Reviewer | Representation | Employment | Consultant | Speakers Bureau | Ownership/Partnership/Principal | Personal Research | Institutional, Organizational, or Other Financial Benefit | Expert Witness |
---|---|---|---|---|---|---|---|---|
Siqin Kye Ye | ACC/AHA TFPM Lead Reviewer | Center for Behavioral Cardiovascular Health–Assistant Professor of Medicine; Cardiology Inpatient Consultation Service–Director; Columbia Doctors–Associate Chief Medical Officer | None | None | None | None | None | None |
John L. Jefferies | Official ACC | University of Tennessee Health Science Center–Jay M. Sullivan Distinguished Chair in Cardiovascular Medicine, Chief of Cardiology |
|
None | None | None | None | |
Pam Peterson | Official ACC | University of Colorado Anschutz Medical Campus–Professor of Medicine, Denver Health Medical Center |
|
None | None |
|
None | None |
Howard J. Eisen | Official AHA | Penn State College of Medicine–Chief, Division of Cardiology | None | None | None | None | None | None |
Janet N. Scheel | Official AHA | Washington University School of Medicine/St. Louis Children’s Hospital–Professor of Pediatrics and Pediatric Cardiologist | None | None | None | None | None | None |
Robert John Mentz | Official HFSA | Duke University School of Medicine–Associate Professor of Medicine, Associate Professor in Population Health Sciences, Member in the Duke Clinical Research Institute | None | None | None | None | ||
Mary Norine Walsh | Content ACC | St. Vincent Heart Center of Indiana–Medical Director Heart Failure and Cardiac Transplantation | None | None | None | None | None | |
Eldrin F. Lewis | Content AHA | Brigham and Women’s Hospital–Associate Physician; Harvard Medical School–Associate Professor of Medicine | None | None | None |
|
||
Nancy M. Albert | Content ACC/AHA | Research and Innovation, Cleveland Clinic Health System & CNS/Kaufman Center for Heart Failure, Heart, Vascular & Thoracic Institute–Associate Chief Nursing Officer |
|
|
None |
|
|
None |
Sana M. Al-Khatib | Content ACC/AHA | Duke University School of Medicine–Professor of Medicine, Member in the Duke Clinical Research Institute |
|
None | None |
|
|
|
Anita Deswal | Content ACC/AHA | Baylor College of Medicine–Chief, Medicine-Cardiology, Michael E. DeBakey VA Medical Center & Baylor College of Medicine; Professor, Medicine-Cardiology, Winters Center for Heart Failure Research | None | None | None |
|
|
None |
Mona Fiuzat | Content ACC/AHA | Duke University School of Medicine–Adjunct Associate Professor, Department of Medicine | None | None | None |
|
None | None |
Adrian F. Hernandez | Content ACC/AHA | Duke University School of Medicine–Vice Dean for Clinical Research | None | None |
|
|
||
J. Herb Patterson | Content ACC/AHA | UNC Eshelman School of Pharmacy–Interim Chair, Division of Pharmacotherapy and Experimental Therapeutics, Professor of Pharmacy, Research Professor of Medicine |
|
None | None | None | None | |
Andrea Russo | Content ACC/AHA | Cooper Medical School of Rowan University–Professor of Medicine and Director; Cardiac Electrophysiology and Arrhythmia Services–Director; Cardiovascular Research Cooper University Hospital Dorrance #393–Program Director, Clinical Cardiac Electrophysiology Fellowship | None | None | None | None | None | |
Paul Varosy | Content ACC/AHA | VA Eastern Colorado Health Care System–Director of Cardiac Electrophysiology | None | None | None |
|
|
None |
This table represents all relationships of reviewers with industry and other entities that were reported at the time of peer review, including those not deemed to be relevant to this document, at the time this document was under review. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review. Please refer to http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/relationships-with-industry-policy for definitions of disclosure categories or additional information about the ACC/AHA Disclosure Policy for Writing Committees.
Significant (greater than $5,000) relationship.
No financial relationship.
This disclosure was entered under the Clinical Trial Enroller category in the ACC’s disclosure system.
ACC indicates American College of Cardiology; AHA, American Heart Association; CNS, Clinical Nurse Specialist; DSMB, Data Safety and Monitoring Board; FDA, U. S. Food and Drug Administration; HFSA, Heart Failure Society of America; NHLBI, National Heart, Lung, and Blood Institute; NIH, National Institutes of Health; PCORI, Patient-Centered Outcomes Research Institute; PI, principal investigator; SCD, sudden cardiac death; TFPM, Task Force on Performance Measures; UNC, University of North Carolina; VA, Veterans Administration; and VT, ventricular tachycardia.